The in-Pharmatechnologist.com team donned our spurs and moseyed on down to San Antonio, Texas to cover the developments from this year's American Association of Pharmaceutical Scientists show.
Amongst the talk of oral delivery methods and advances in bioavailability, we also scouted the convention's floor to bring you all the news AAPS 2013 had to offer.
02-Dec-2013 - Almac says it is in a unique position to offer Carbon-14 ADME radiolabeling for the growing antibody-drug conjugate (ADC) market and has already performed the service on a Pfizer candidate....
13-Nov-2013 - The US FDA is working with GEA to validate continuous manufacturing as the pharma industry enters “the start of the end” for batch manufacturing, according to GEA.
13-Nov-2013 - Drug delivery experts say fixed dose combination (FDC) products for non-oral forms can benefit both the manufacturer and the patient.
13-Nov-2013 - Unclear terms in US biosimilars laws and the high cost of filing with the Food and Drug Administration (FDA) has set the stage for legal battles according to a lawyer...
12-Nov-2013 - There are multiple ways to make amorphous dispersions in order to enhance bioavailability but spray dry dispersion (SDD) is often the most applicable, Bend Research says.
12-Nov-2013 - Understanding how a drug will interact with food is vital even if predicting it accurately during development can be a challenge according to speakers at AAPS yesterday.
11-Nov-2013 - [View the story "AAPS at the Alamo" on Storify]